Pipeline by therapeutic class

        Total
       Small molecule drug 96
       Monoclonal antibody/polyclonal fragment 10
       Vaccine (prophylactic/therapeutic) 19
       Biologic 30
       Nucleic acid-based therapy 16
       Pro-drug/photodynamic therapy 4
       Stem cell/regenerative 11

London Biotechnology Network

The London Biotechnology Network (LBN) is a business network of over 800 organisations and 2000 individuals from all facets of the industry: academic, biopharma, professional services, finance, law and facilities. The LBN strives to provide members with relevant information and networking opportunities to foster industry interactions and innovation.

Find out more »

News and events

26/01/2010 LBN Lunchtime Seminar (11.30:14.00hrs): Collaborative funding opportunities for life science SMEs with Academia

This special LBN seminar is held to launch the findings of the recent research undertaken by King's College London on how SMEs and Academia interact and will include presentations on various funding opportunities to assist young companies.

03/02/2010 Feb 3rd Biowednesday (18.00-21.00hrs): Trading up: exits for investors and founders when the IPO markets are shut

LBN's regular networking event.

Kindly hosted and sponsored by Imperial College Incubator

23/02/2010 Business of Healthcare in London (18.00 - 21.00hrs): How can universities globailsie their business and promote the London brand

First in the series of these new events delivered by Pinsent Masosn and London First looking at the opportunities and challenges offered by the exciting critical mass and world renowned excellence of London's healthcare education, research and delivery whether public or private sector.

Further details: contact Tony Jones on tjones@londonfirst.co.uk

23/02/2010 London First - Pinsent Masons Business of Healthcare in London Series

Following a very successful pilot event this year, London First and Pinsent Masons will run a series of evening session between February and July 2010 looking at the opportunities and challenges for the education, research, NHS and independent sector in this sector. Levearging excellence in research and training to benefit patients, globalising brands and the role of large retailers are all set to be discussed.

For further details contact Tony Jones on tjones@londonfirst.co.uk

More news and events »

Dec (Genesis) 2009 newsletter

More newsletters »

Become a member

The LBN currently has over 2000 individual members from around 800 organisations across a wide range of life science industry sectors, including biopharma companies, academics, investors, facility managers, service providers, consultants and more.

Find out more »

Jobs

There are currently no vacancies listed.

More jobs »

Designed and produced by Oculus